ASEAN PE/VC in the Era of COVID-19: Lessons Learned to Date and Navigating the Future

May 21, 2020 May 21, 2020
9:00AM - 10:10AM (SGT) Online via Zoom Meeting

SVCA in collaboration with EMPEA, will be organising a private virtual meeting to discuss the impact of COVID-19 on private equity and venture capital in Southeast Asia on Thursday, 21 May 2020.

EMPEA's Managing Director of Research, Jeff Schlapinski, will provide context and present relevant findings from EMPEA's Year-End 2019 Global Private Capital Industry Data & Statistics with a focus on Southeast Asia.

Panels facilitated by EMPEA's ASEAN Representative Steven Okun and SVCA's Director Doris Yee, will include the region’s most active fund managers to discuss the outlook for PE and VC in the region as a result of COVID-19, with an eye to unpacking the challenges faced by the private capital industry in these uncertain times.

EMPEA and SVCA members receive complimentary access to the meeting.


We regret that we are unable to refund you once your registration is confirmed. Please send a replacement if there are any last minute changes to your schedule and inform us at least 2 working days prior. A no-show fee equivalent to the registration fee will be imposed for those who have registered but payment not received by us. SVCA Full Corporate Members are applicable for the complimentary/ member's rate seat with the provision that membership fees have been paid prior in full. SVCA Associate Members are applicable for the member's rate with the provision that membership fees have been paid prior in full. Please note that information collected may be shared with 3rd parties such as partners and/ or sponsors. SVCA may (at its sole discretion) change the format, speakers, participants, content, venue location and programme or any other aspect of the event at any time and for any reason, whether or not due to a Force Majeure Event, in each case without liability. Photos and videos may be taken of the event for marketing purposes. Thank you for your co-operation.


TEL: +65 6224 7001